Recent Activity

Loading...

EOLS

Evolus, Inc. · NASDAQ

Performance

+3.5%

1W

+12.78%

1M

+0.52%

3M

+50.67%

6M

+29.06%

YTD

+37.55%

1Y

Profile

Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. The company offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. It serves self-pay aesthetic healthcare market. Evolus, Inc. was incorporated in 2012 and is headquartered in Newport Beach, California.

Investment Analysis Report: EOLS

Overview:

EOLS is a pharmaceutical company operating in the Health Technology sector with a market capitalization of $772,677,774. The company's financial data includes the latest 3 annual balance sheets, income statements, and cash flow statements, as well as the latest 4 quarterly balance sheets, income stateme...

See more ...

Technical Analysis of EOLS 2024-05-10

Overview:

In analyzing the technical indicators for EOLS over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key indicators, we aim to offer valuable insights and predictions for informed deci...

See more ...

Recent News & Updates